ArticleCJC open2026
Machine Learning-Based Model for Predicting Acute Kidney Injury in Patients Hospitalized with Heart Failure: Development and Validation Study.
Article in CJC open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From black box to glass box: explainable artificial intelligence for acute kidney injury prediction-a scoping review and the GLASS-AKI translational framework proposal.International urology and nephrology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute kidney injury (AKI) substantially worsens outcomes in patients hospitalized with heart failure, yet effective early prediction tools remain limited. This study aimed to develop and validate a machine learning-based model for AKI prediction in heart failure patients. Methods: We retrospectively analyzed 870 patients hospitalized for heart failure between October 2017 and June 2024. Missing values (<30%) were imputed, and feature selection was performed using LASSO and backward stepwise logistic regression. Five machine learning models (XGBoost, LightGBM, Logistic Regression, Support Vector Machine, and Decision Tree) were developed and evaluated using ROC curves, precision-recall curves, calibration plots, and decision curve analysis. Results: AKI occurred in 271 patients (31.2%). Baseline comparisons showed significant differences in renal function and electrolyte levels between AKI and non-AKI groups (all P<0.05). Ten potential predictors were identified by LASSO, and seven remained significant after logistic regression. Among all models, XGBoost achieved the best discrimination with AUC of 0.927 (95% CI: 0.902-0.951) in the validation set. It showed excellent sensitivity (0.761), specificity (0.967), and positive predictive value (0.911). Calibration and decision curve analyses confirmed strong agreement and net clinical benefit. SHAP analysis indicated chronic kidney disease (OR=2.805, 95% CI: 1.461-5.383) and electrolyte disturbances as key predictors. Conclusions: The proposed machine learning-based model accurately predicts AKI risk in heart failure patients, outperforming conventional methods. Its interpretability and robust performance suggest promising utility as a clinical decision support tool, warranting external validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.